How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact

BACKGROUND: Randomized controlled trials reported that pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine rarely selects for drug resistance. However, drug resistance due to PrEP is not completely understood. In daily practice, PrEP will not be used under the well-controlled conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimitrov, Dobromir T., Boily, Marie-Claude, Hallett, Timothy B., Albert, Jan, Boucher, Charles, Mellors, John W., Pillay, Deenan, van de Vijver, David A. M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938235/
https://www.ncbi.nlm.nih.gov/pubmed/27391094
http://dx.doi.org/10.1371/journal.pone.0158620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938235/
https://www.ncbi.nlm.nih.gov/pubmed/27391094
http://dx.doi.org/10.1371/journal.pone.0158620

Ejemplares similares